Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

[1]  A. Randolph,et al.  Variation in Early Anakinra Use and Short‐Term Outcomes in Multisystem Inflammatory Syndrome in Children , 2023, Arthritis & rheumatology.

[2]  P. Surén,et al.  COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway. , 2022, Pediatrics.

[3]  L. S. Schmidt,et al.  Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. , 2022, JAMA pediatrics.

[4]  D. Sahoo,et al.  An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease , 2022, Nature Communications.

[5]  J. Karakaya,et al.  The difference of the inflammatory milieu in MIS-C and severe COVID-19 , 2022, Pediatric Research.

[6]  Yijin Xiang,et al.  Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children , 2022, JAMA pediatrics.

[7]  L. Henderson,et al.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 , 2022, Arthritis & rheumatology.

[8]  M. Fogel,et al.  Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID‐19 Infections , 2022, Journal of the American Heart Association.

[9]  I. Maccora,et al.  The Role of Anti-IL-1 Treatment in MIS-C Patients , 2021, Expert opinion on biological therapy.

[10]  M. Pollack,et al.  Strain Echocardiography and Myocardial Dysfunction in Critically Ill Children With Multisystem Inflammatory Syndrome Unrecognized by Conventional Echocardiography: A Retrospective Cohort Analysis , 2021, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[11]  P. Kearns,et al.  The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery , 2021, iScience.

[12]  R. DeBiasi,et al.  Cardiac echocardiogram findings of severe acute respiratory syndrome coronavirus-2-associated multi-system inflammatory syndrome in children , 2021, Cardiology in the Young.

[13]  S. Prahalad,et al.  Intravenous administration of anakinra in children with macrophage activation syndrome , 2021, Pediatric Rheumatology.

[14]  C. Hoggart,et al.  Treatment of Multisystem Inflammatory Syndrome in Children , 2021, The New England journal of medicine.

[15]  Manish M Patel,et al.  Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes , 2021, The New England journal of medicine.

[16]  R. DeBiasi,et al.  Multisystem Inflammatory Syndrome of Children: Sub-phenotypes, Risk Factors, Biomarkers, Cytokine Profiles and Viral Sequencing. , 2021, The Journal of pediatrics.

[17]  P. D’argenio,et al.  Post-discharge telephonic follow-up of pediatric patients affected by SARS-CoV2 infection in a single Italianpediatric COVID center: a safe and feasible way to monitor children after hospitalization , 2021, Italian Journal of Pediatrics.

[18]  I. Maccora,et al.  Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment , 2021, Critical Care.

[19]  A. Belot,et al.  Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. , 2021, JAMA.

[20]  L. Henderson,et al.  MIS-C: early lessons from immune profiling , 2020, Nature Reviews Rheumatology.

[21]  I. Jordan,et al.  Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain , 2020, Critical Care.

[22]  I. Maccora,et al.  The off-label use of anakinra in pediatric systemic autoinflammatory diseases , 2020, Therapeutic advances in musculoskeletal disease.

[23]  M. Malim,et al.  Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.

[24]  K. Sullivan,et al.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.

[25]  C. Berul,et al.  Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease? , 2020, Trends in Cardiovascular Medicine.

[26]  B. Scholefield,et al.  Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital , 2020, Pediatric Cardiology.

[27]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[28]  P. Zachariah,et al.  Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. , 2020, JAMA.

[29]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[30]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[31]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[32]  J. Voigt,et al.  Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors: The EACVI/ASE Inter-Vendor Comparison Study. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[33]  C. Gabay,et al.  IL-1 pathways in inflammation and human diseases , 2010, Nature Reviews Rheumatology.

[34]  Jérémie F. Cohen,et al.  Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study , 2020, BMJ.

[35]  Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study , 2022 .

[36]  J. Santelli,et al.  Perspectives on Sexual and Reproductive Health Contraceptive Use and Pregnancy Risk among U.s. High School Students, 1991–2003 , 2022 .